| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription corepressor activity | HDAC9 BCORL1 GON4L EID1 ZNF541 DNMT3B MED1 DRAP1 NCOR1 ZBTB32 SPEN SCAI | 1.08e-05 | 229 | 223 | 12 | GO:0003714 |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 1.35e-05 | 5 | 223 | 3 | GO:0061628 | |
| GeneOntologyMolecularFunction | p53 binding | 2.44e-05 | 77 | 223 | 7 | GO:0002039 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 6.62e-05 | 62 | 223 | 6 | GO:0003678 | |
| GeneOntologyMolecularFunction | general transcription initiation factor activity | 1.11e-04 | 68 | 223 | 6 | GO:0140223 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 2.17e-04 | 27 | 223 | 4 | GO:0001091 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor activity | 2.82e-04 | 52 | 223 | 5 | GO:0016251 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 3.35e-04 | 83 | 223 | 6 | GO:1990841 | |
| GeneOntologyMolecularFunction | endoplasmic reticulum-organelle membrane tether activity | 3.70e-04 | 3 | 223 | 2 | GO:0170009 | |
| GeneOntologyMolecularFunction | endoplasmic reticulum-autophagosome adaptor activity | 3.70e-04 | 3 | 223 | 2 | GO:0140506 | |
| GeneOntologyMolecularFunction | autophagosome-membrane adaptor activity | 3.70e-04 | 3 | 223 | 2 | GO:0160183 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 5.40e-04 | 34 | 223 | 4 | GO:0046966 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | RALGAPA1 PDGFB FBXO7 TAF1 TAF7 TAF1L ABTB2 IKZF3 FXR2 DRAP1 KATNA1 ZBTB1 TAF3 | 5.64e-04 | 398 | 223 | 13 | GO:0046982 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 5.67e-04 | 127 | 223 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | XIRP1 MYLK SPTB EML6 ADGRV1 MAP3K1 TTBK1 MTUS1 PLEKHM2 SSH3 TLN2 KIF17 PLS3 CACNA1C AKAP5 ANK2 DYRK1A CORO1B KATNA1 PTPRT AGBL4 SMTNL1 MICALL2 TTLL2 UNC13A | 5.88e-04 | 1099 | 223 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | chromatin binding | ZNF609 PATZ1 GATA6 TSPYL1 TTF1 FOXO4 TAF1 TAF1L RAD17 DNMT3B RAD51 IKZF3 CHD8 REST MED1 BAHD1 NCOR1 GTF2H1 CABIN1 | 6.61e-04 | 739 | 223 | 19 | GO:0003682 |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 7.34e-04 | 4 | 223 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 7.41e-04 | 64 | 223 | 5 | GO:0140296 | |
| GeneOntologyMolecularFunction | transcription factor binding | HDAC9 GATA6 KDM5D FOXO4 TAF1 TAF7 TAF1L CXXC5 PPP1R13B REST MED1 DRAP1 PTPRT NCOR1 TAF3 GTF2H1 EHMT1 SPEN TP53BP2 | 8.27e-04 | 753 | 223 | 19 | GO:0008134 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | HDAC9 GATA6 KDM5D TAF1 TAF7 TAF1L REST MED1 PTPRT NCOR1 GTF2H1 SPEN TP53BP2 | 8.67e-04 | 417 | 223 | 13 | GO:0061629 |
| GeneOntologyMolecularFunction | histone deacetylase binding | 1.34e-03 | 147 | 223 | 7 | GO:0042826 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP7B MCM3 MDN1 RECQL4 KIF17 DDX4 RAD17 RAD51 CHD8 KATNA1 HELQ ATP2A1 ATP2A3 | 1.44e-03 | 441 | 223 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | MYLK MAP3K1 RPS6KC1 TTBK1 ALPK3 AKT1 TAF1 TAF1L LTBP4 DYRK1A MAPK7 PRKX DCLK1 | 1.59e-03 | 446 | 223 | 13 | GO:0004674 |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.81e-03 | 78 | 223 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | helicase activity | 2.03e-03 | 158 | 223 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | single-stranded DNA helicase activity | 2.06e-03 | 23 | 223 | 3 | GO:0017116 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | HDAC9 BRPF3 ZMPSTE24 BCORL1 NASP TSPYL1 KDM5D TTF1 TRRAP CENPK GTF3C4 TAF1 TAF7 TAF1L DDX4 RAD17 DNMT3B RAD51 DYRK1A PPHLN1 CHD8 REST MED1 ZBTB1 BAHD1 NCOR1 TAF3 PWWP2B EHMT1 CABIN1 | 2.48e-07 | 999 | 218 | 30 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | HDAC9 BRPF3 ZMPSTE24 BCORL1 NASP TSPYL1 KDM5D TTF1 TRRAP GTF3C4 TAF1 TAF1L DDX4 RAD17 DNMT3B DYRK1A PPHLN1 CHD8 REST ZBTB1 BAHD1 NCOR1 PWWP2B EHMT1 CABIN1 | 9.73e-06 | 896 | 218 | 25 | GO:0006325 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | RALGAPA1 HDAC9 PDGFB PATZ1 BCORL1 GATA6 GON4L ZNF469 EID1 TAF1 TAF7 MAGEC2 NOTCH3 ZNF541 DNMT3B GLIS3 CXXC5 PPHLN1 CHD8 REST MED1 DRAP1 ZBTB1 BAHD1 TFAP4 NCOR1 SMTNL1 TAF3 ZBTB32 ZBTB10 EHMT1 SPEN SCAI | 1.18e-05 | 1399 | 218 | 33 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | RALGAPA1 HDAC9 PDGFB PATZ1 BCORL1 GATA6 GON4L ZNF469 EID1 TAF1 TAF7 MAGEC2 NOTCH3 ZNF541 DNMT3B GLIS3 CXXC5 PPHLN1 CHD8 REST MED1 DRAP1 ZBTB1 BAHD1 TFAP4 NCOR1 SMTNL1 TAF3 ZBTB32 ZBTB10 EHMT1 SPEN SCAI | 1.45e-05 | 1413 | 218 | 33 | GO:1902679 |
| GeneOntologyBiologicalProcess | chromatin remodeling | HDAC9 BRPF3 ZMPSTE24 NASP TSPYL1 KDM5D TTF1 GTF3C4 TAF1 TAF1L DDX4 DNMT3B DYRK1A PPHLN1 CHD8 REST ZBTB1 BAHD1 PWWP2B EHMT1 CABIN1 | 4.17e-05 | 741 | 218 | 21 | GO:0006338 |
| GeneOntologyBiologicalProcess | heart development | HDAC9 XIRP1 ZMPSTE24 PDGFB GATA6 ALPK3 CPLANE1 VCAM1 CACNA1C HSPG2 FAT4 NPY2R ANK2 DYRK1A REST ODAD2 MED1 RBM20 VCAN NPRL3 TP53BP2 | 5.67e-05 | 757 | 218 | 21 | GO:0007507 |
| GeneOntologyCellularComponent | nuclear DNA-directed RNA polymerase complex | 2.01e-04 | 113 | 221 | 7 | GO:0055029 | |
| GeneOntologyCellularComponent | DNA-directed RNA polymerase complex | 2.36e-04 | 116 | 221 | 7 | GO:0000428 | |
| GeneOntologyCellularComponent | RNA polymerase complex | 2.76e-04 | 119 | 221 | 7 | GO:0030880 | |
| GeneOntologyCellularComponent | MLL1 complex | 3.47e-04 | 32 | 221 | 4 | GO:0071339 | |
| GeneOntologyCellularComponent | RNA polymerase II, holoenzyme | 3.65e-04 | 89 | 221 | 6 | GO:0016591 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 3.91e-04 | 33 | 221 | 4 | GO:0044665 | |
| GeneOntologyCellularComponent | transcription regulator complex | HDAC9 GATA6 TRRAP GTF3C4 TAF1 TAF7 TAF1L ZNF541 REST MED1 DRAP1 TFAP4 NCOR1 TAF3 GTF2H1 SPEN | 6.34e-04 | 596 | 221 | 16 | GO:0005667 |
| GeneOntologyCellularComponent | USH2 complex | 6.58e-04 | 4 | 221 | 2 | GO:1990696 | |
| MousePheno | abnormal heart ventricle morphology | HDAC9 XIRP1 ZMPSTE24 PDGFB ITGB3 ITGB8 MAP3K1 YIPF5 ALPK3 CPLANE1 PLOD2 LTBP4 VCAM1 DNMT3B CACNA1C HSPG2 ODAD2 MED1 PIP5K1C RBM20 NCOR1 VCAN NPRL3 MAPK7 RAI2 TP53BP2 | 8.27e-06 | 793 | 178 | 26 | MP:0005294 |
| Domain | Ank_2 | BCORL1 TRPV2 ABTB2 NOTCH3 ANK2 PPP1R13B ANKRA2 KANK3 ANKRD34A EHMT1 TP53BP2 | 5.07e-05 | 215 | 220 | 11 | PF12796 |
| Domain | Ankyrin_rpt | TRPM4 BCORL1 TRPV2 ABTB2 NOTCH3 ANK2 PPP1R13B ANKRA2 KANK3 ANKRD34A EHMT1 TP53BP2 | 6.77e-05 | 262 | 220 | 12 | IPR002110 |
| Domain | Ank | BCORL1 TRPV2 ABTB2 NOTCH3 ANK2 PPP1R13B ANKRA2 KANK3 ANKRD34A EHMT1 TP53BP2 | 8.59e-05 | 228 | 220 | 11 | PF00023 |
| Domain | INB | 8.64e-05 | 8 | 220 | 3 | SM00187 | |
| Domain | Integrin_bsu_VWA | 8.64e-05 | 8 | 220 | 3 | IPR002369 | |
| Domain | Integrin_beta | 8.64e-05 | 8 | 220 | 3 | PF00362 | |
| Domain | Integrin_bsu | 1.29e-04 | 9 | 220 | 3 | IPR015812 | |
| Domain | INTEGRIN_BETA | 1.29e-04 | 9 | 220 | 3 | PS00243 | |
| Domain | PSI_integrin | 1.29e-04 | 9 | 220 | 3 | PF17205 | |
| Domain | Integin_beta_N | 1.29e-04 | 9 | 220 | 3 | IPR033760 | |
| Domain | TFIID_sub1_DUF3591 | 1.38e-04 | 2 | 220 | 2 | IPR022591 | |
| Domain | TBP-binding | 1.38e-04 | 2 | 220 | 2 | PF09247 | |
| Domain | DUF3591 | 1.38e-04 | 2 | 220 | 2 | PF12157 | |
| Domain | TAF_II_230-bd | 1.38e-04 | 2 | 220 | 2 | IPR009067 | |
| Domain | - | 1.38e-04 | 2 | 220 | 2 | 1.10.1100.10 | |
| Domain | TAF1_animal | 1.38e-04 | 2 | 220 | 2 | IPR011177 | |
| Domain | - | BCORL1 TRPV2 ABTB2 NOTCH3 ANK2 PPP1R13B ANKRA2 KANK3 ANKRD34A EHMT1 TP53BP2 | 1.80e-04 | 248 | 220 | 11 | 1.25.40.20 |
| Domain | ANK | BCORL1 TRPV2 ABTB2 NOTCH3 ANK2 PPP1R13B ANKRA2 KANK3 ANKRD34A EHMT1 TP53BP2 | 2.00e-04 | 251 | 220 | 11 | SM00248 |
| Domain | ANK_REPEAT | BCORL1 TRPV2 ABTB2 NOTCH3 ANK2 PPP1R13B ANKRA2 KANK3 ANKRD34A EHMT1 TP53BP2 | 2.14e-04 | 253 | 220 | 11 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | BCORL1 TRPV2 ABTB2 NOTCH3 ANK2 PPP1R13B ANKRA2 KANK3 ANKRD34A EHMT1 TP53BP2 | 2.22e-04 | 254 | 220 | 11 | IPR020683 |
| Domain | ANK_REP_REGION | BCORL1 TRPV2 ABTB2 NOTCH3 ANK2 PPP1R13B ANKRA2 KANK3 ANKRD34A EHMT1 TP53BP2 | 2.22e-04 | 254 | 220 | 11 | PS50297 |
| Domain | EGF_1 | ITGB3 ITGB6 ITGB8 MEP1B LTBP4 NOTCH3 HSPG2 FAT4 EGF VCAN ASTN1 | 2.29e-04 | 255 | 220 | 11 | PS00022 |
| Domain | EGF-like_CS | ITGB3 ITGB6 ITGB8 MEP1B LTBP4 NOTCH3 HSPG2 FAT4 EGF VCAN ASTN1 | 2.80e-04 | 261 | 220 | 11 | IPR013032 |
| Domain | EGF_2 | ITGB3 ITGB6 ITGB8 MEP1B LTBP4 NOTCH3 HSPG2 FAT4 EGF VCAN ASTN1 | 3.19e-04 | 265 | 220 | 11 | PS01186 |
| Domain | P-type_ATPase_IIA | 4.11e-04 | 3 | 220 | 2 | IPR005782 | |
| Domain | MAM_1 | 8.06e-04 | 16 | 220 | 3 | PS00740 | |
| Domain | - | 8.16e-04 | 4 | 220 | 2 | 1.20.5.630 | |
| Domain | BTB | 9.29e-04 | 131 | 220 | 7 | PF00651 | |
| Domain | MYB_LIKE | 1.01e-03 | 38 | 220 | 4 | PS50090 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | BRPF3 AKT1 TAF1 TAF7 TAF1L RAD17 PPP1R13B TAF3 EHMT1 TP53BP2 | 1.20e-05 | 157 | 160 | 10 | MM15226 |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | BRPF3 AKT1 TAF1 TAF7 TAF1L RAD17 PPP1R13B TAF3 EHMT1 TP53BP2 | 1.42e-05 | 160 | 160 | 10 | M27498 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRPM4 RIN3 PCNX3 CYTH1 EXTL3 TRRAP MDN1 PLEKHM2 TLN2 AKT1 LTBP4 BCL2L13 ABTB2 RAD51 HSPG2 DYRK1A CHD8 SMG5 CORO1B PIP5K1C BAHD1 RABL6 NCOR1 THADA PWWP2B KANK3 NPRL3 ANKRD34A EHMT1 LRRC14 CABIN1 SPEN ATP2A3 | 2.43e-13 | 1105 | 224 | 33 | 35748872 |
| Pubmed | ZNF609 ZMPSTE24 PSMA5 BCORL1 GATA6 GON4L TRRAP SEPTIN6 TAF1 CPSF2 TAF1L NXF1 SYNCRIP HSPG2 IKZF3 PITRM1 COX5B PPP1R13B CHD8 SEC22B SMG5 ZBTB1 TFAP4 RBM20 ARID3B CASP12 NCOR1 TAF3 ZFHX4 ZBTB10 EHMT1 MRTO4 CABIN1 SPEN RAI2 | 1.17e-11 | 1429 | 224 | 35 | 35140242 | |
| Pubmed | ZNF609 PATZ1 TSPYL1 MDN1 INTS2 MAGEC2 GLIS3 CHD8 CORO1B ARID3B NCOR1 ZFHX4 ZBTB10 SPEN | 5.11e-09 | 282 | 224 | 14 | 23667531 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SETX PATZ1 PSMA5 TTF1 TRRAP GTF3C4 MDN1 RECQL4 FOXO4 CPSF2 PLOD2 NOTCH3 DYRK1A SMG5 DRAP1 RFX2 TFAP4 ARID3B NCOR1 ZFHX4 ZBTB10 CABIN1 SPEN | 9.78e-09 | 857 | 224 | 23 | 25609649 |
| Pubmed | TRPM4 SETX PCNX3 CYTH1 GON4L TSPYL1 TTF1 TRRAP MDN1 INTS2 CPSF2 TAF1L PLS3 NXF1 ZCCHC9 TBC1D30 COX5B CXXC5 DYRK1A PPHLN1 CHD8 MED1 RAB11FIP1 GTF2H1 MICALL2 EHMT1 PALM3 MPHOSPH10 ZBTB11 SPEN DCLK1 | 1.07e-08 | 1497 | 224 | 31 | 31527615 | |
| Pubmed | SETX ZMPSTE24 CYP17A1 GATA6 NASP SEPTIN6 RPS6KC1 INTS2 FBXO7 PJA1 CPSF2 CPLANE1 PARPBP BAIAP3 ARHGEF6 FHIP2B RAD17 DYRK1A ARHGEF18 VCAN ZBTB10 MPHOSPH10 TANGO2 DCLK1 VPS13B | 4.20e-08 | 1084 | 224 | 25 | 11544199 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF609 SETX PATZ1 BCORL1 GATA6 TTF1 TRRAP GTF3C4 YIPF5 MDN1 INTS2 CPSF2 TAF7 TAF1L NXF1 SYNCRIP CXXC5 PPHLN1 SEC22B REST MED1 TFAP4 NCOR1 TIGD2 EHMT1 CABIN1 SPEN | 8.90e-08 | 1294 | 224 | 27 | 30804502 |
| Pubmed | 2.06e-07 | 9 | 224 | 4 | 12665565 | ||
| Pubmed | TAF7: a possible transcription initiation check-point regulator. | 2.64e-07 | 3 | 224 | 3 | 16407123 | |
| Pubmed | TAFII55 binding to TAFII250 inhibits its acetyltransferase activity. | 2.64e-07 | 3 | 224 | 3 | 11592977 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 TRPM4 ZNF609 TTC21A SPTB ADGRV1 TTF1 TRRAP SEPTIN6 INTS2 PLCB4 BAIAP3 NOTCH3 MOCOS CACNA1C AFF3 CXXC5 TMEM63C ARHGEF18 PPHLN1 TFAP4 THADA PWWP2B KNDC1 EHMT1 TANGO2 PRKX VPS13B | 4.17e-07 | 1489 | 224 | 28 | 28611215 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SETX BCORL1 NASP TRRAP GTF3C4 TAF1 ZCCHC9 CHD8 MED1 ARID3B TAF3 FAM169A ZBTB10 EHMT1 ZBTB11 CABIN1 SPEN | 5.12e-07 | 608 | 224 | 17 | 36089195 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | MCM3 TTF1 TRRAP NXF1 KRT15 FXR2 ARHGEF18 PPHLN1 CHD8 ARID3B MRTO4 MPHOSPH10 SPEN DCLK1 | 5.19e-07 | 410 | 224 | 14 | 26949251 |
| Pubmed | NASP MCM3 TRRAP GTF3C4 TAF1 TAF7 PLS3 PPP1R13B CHD8 CORO1B MED1 ARID3B NCOR1 TAF3 SPEN TP53BP2 | 6.51e-07 | 549 | 224 | 16 | 38280479 | |
| Pubmed | ZNF609 BCORL1 GTF3C4 TAF1 NXF1 RAD51 CHD8 ZBTB1 RBM20 NCOR1 ZFHX4 ZBTB10 ZBTB11 TP53BP2 | 6.53e-07 | 418 | 224 | 14 | 34709266 | |
| Pubmed | HDAC9 CYTH1 SPTB NASP SYNC EXTL3 ITGB8 GTF3C4 RETREG1 FBXO7 TLN2 TAF1 PJA1 SULT4A1 ANK2 ZNF584 CXXC5 DYRK1A SMG5 ASTN1 ZNF76 ZBTB11 CABIN1 DCLK1 SCAI | 9.95e-07 | 1285 | 224 | 25 | 35914814 | |
| Pubmed | SETX PSMA5 NASP MCM3 STAP1 SSH3 TLN2 ARHGEF6 MOCOS PPHLN1 CHD8 MED1 RAB11FIP1 NCOR1 SPEN | 1.11e-06 | 503 | 224 | 15 | 16964243 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | MCM3 TRRAP GTF3C4 RPS6KC1 PLOD2 NXF1 FXR2 DYRK1A CHD8 MED1 ZBTB1 ZBTB10 MPHOSPH10 ZBTB11 | 1.20e-06 | 440 | 224 | 14 | 34244565 |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | HDAC9 GATA6 MCM3 KDM5D CENPK TAF7 RAD51 FXR2 ZNF584 GLIS3 REST MED1 RFX2 ZBTB1 ARID3B GTF2H1 ZBTB32 ANKRA2 EHMT1 SPEN | 1.21e-06 | 877 | 224 | 20 | 20211142 |
| Pubmed | PATZ1 CYTH1 MCM3 MDN1 TLN2 CPSF2 UNC79 ANK2 FXR2 HCN3 DYRK1A ARHGEF18 CHD8 CORO1B ZBTB1 NCOR1 EHMT1 CABIN1 UNC13A DCLK1 TP53BP2 | 1.32e-06 | 963 | 224 | 21 | 28671696 | |
| Pubmed | 2.61e-06 | 5 | 224 | 3 | 27044757 | ||
| Pubmed | 2.66e-06 | 94 | 224 | 7 | 16325481 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PSMA5 NASP MCM3 TRRAP GTF3C4 MDN1 TLN2 CPSF2 ARHGEF6 MOCOS REST MED1 TFAP4 NCOR1 TAF3 PWWP2B TKT SPEN | 3.22e-06 | 774 | 224 | 18 | 15302935 |
| Pubmed | BRPF3 ZNF609 ATP7B PATZ1 TSPYL1 TRRAP ZNF469 MTUS1 TAF1 TAF7 LTBP4 FXR2 CHD8 RAB11FIP1 C11orf16 THADA TAF3 GTF2H1 PWWP2B ZFHX4 ZBTB10 EHMT1 | 3.75e-06 | 1116 | 224 | 22 | 31753913 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | NASP EID1 FBXO7 AKT1 CPLANE1 KIF17 LTBP4 NOTCH3 CACNA1C FXR2 PPHLN1 CORO1B MAPK7 RAI2 ADAMTSL2 | 4.10e-06 | 560 | 224 | 15 | 21653829 |
| Pubmed | Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function. | 4.78e-06 | 18 | 224 | 4 | 7933101 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ZNF609 KDM5D ITGB3 MAP3K1 ZNF469 DNMT3B GLIS3 ARHGEF18 PIP5K1C NCOR1 ANKRA2 SPEN TP53BP2 | 5.03e-06 | 430 | 224 | 13 | 35044719 |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 5.14e-06 | 146 | 224 | 8 | 23892456 | |
| Pubmed | 5.20e-06 | 6 | 224 | 3 | 24216753 | ||
| Pubmed | Genetic predictors of depressive symptoms in cardiac patients. | 5.20e-06 | 6 | 224 | 3 | 18618671 | |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | SETX MCM3 SEPTIN6 EID1 AKT1 BCL2L13 IKZF3 KRT15 FXR2 GLIS3 HELQ ZBTB1 ZBTB32 USHBP1 TKT MAPK7 TP53BP2 | 7.39e-06 | 742 | 224 | 17 | 26871637 |
| Pubmed | Dominant and redundant functions of TFIID involved in the regulation of hepatic genes. | 8.36e-06 | 43 | 224 | 5 | 18722179 | |
| Pubmed | ZNF609 SETX TSPYL1 GTF3C4 MDN1 RECQL4 RAD51 MED1 ZBTB1 TFAP4 GTF2H1 CABIN1 SCAI | 8.79e-06 | 453 | 224 | 13 | 29656893 | |
| Pubmed | 9.05e-06 | 7 | 224 | 3 | 20864106 | ||
| Pubmed | 9.05e-06 | 7 | 224 | 3 | 36717601 | ||
| Pubmed | 9.05e-06 | 7 | 224 | 3 | 27956497 | ||
| Pubmed | 1.00e-05 | 76 | 224 | 6 | 22323595 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | GON4L TSPYL1 TRRAP GTF3C4 MDN1 TAF1 CPSF2 SYNCRIP FXR2 CHD8 MED1 TKT | 1.08e-05 | 394 | 224 | 12 | 27248496 |
| Pubmed | ZNF609 TAF1 KIF17 LTBP4 NXF1 HSPG2 FAT4 FXR2 DRAP1 NCOR1 ZBTB32 USHBP1 SPEN RAI2 TP53BP2 | 1.09e-05 | 608 | 224 | 15 | 16713569 | |
| Pubmed | Identification of NPM-ALK interacting proteins by tandem mass spectrometry. | 1.30e-05 | 47 | 224 | 5 | 14968112 | |
| Pubmed | TAF9b (formerly TAF9L) is a bona fide TAF that has unique and overlapping roles with TAF9. | 2.15e-05 | 9 | 224 | 3 | 15899866 | |
| Pubmed | TBR1 regulates autism risk genes in the developing neocortex. | 2.15e-05 | 9 | 224 | 3 | 27325115 | |
| Pubmed | 2.15e-05 | 52 | 224 | 5 | 28893950 | ||
| Pubmed | 2.23e-05 | 233 | 224 | 9 | 37704626 | ||
| Pubmed | ZMPSTE24 MYLK EML6 CHRNA1 RPS6KC1 MDN1 SCN9A RETREG1 ZNF541 SYNCRIP DNMT3B CACNA1C AKAP5 KRT15 ANK2 PCDHGA1 NCOR1 TKT FAM169A MPHOSPH10 ZBTB11 SPEN ATP2A1 ATP2A3 | 2.24e-05 | 1442 | 224 | 24 | 35575683 | |
| Pubmed | SPTB GON4L RETREG1 TAF1 NOTCH3 HSPG2 ANK2 GLIS3 PPHLN1 NCOR1 TKT MRTO4 ATP2A1 | 2.32e-05 | 497 | 224 | 13 | 23414517 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | CFAP251 PATZ1 TLN2 CPLANE1 NXF1 FHIP2B FXR2 PPHLN1 KATNA1 ZFHX4 SPEN | 2.52e-05 | 361 | 224 | 11 | 26167880 |
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 2.62e-05 | 27 | 224 | 4 | 31541017 | |
| Pubmed | 2.84e-05 | 55 | 224 | 5 | 10926756 | ||
| Pubmed | 3.06e-05 | 10 | 224 | 3 | 12738788 | ||
| Pubmed | 3.38e-05 | 57 | 224 | 5 | 18022353 | ||
| Pubmed | 3.98e-05 | 251 | 224 | 9 | 28077445 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 19920174 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 34762273 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 15757645 | ||
| Pubmed | Novel functions for TAF7, a regulator of TAF1-independent transcription. | 4.13e-05 | 2 | 224 | 2 | 20937824 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 20671242 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 22842574 | ||
| Pubmed | REST regulates DYRK1A transcription in a negative feedback loop. | 4.13e-05 | 2 | 224 | 2 | 21252229 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 20034025 | ||
| Pubmed | Structural and functional insight into TAF1-TAF7, a subcomplex of transcription factor II D. | 4.13e-05 | 2 | 224 | 2 | 24927529 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 12897056 | ||
| Pubmed | CHD8 haploinsufficiency results in autistic-like phenotypes in mice. | 4.13e-05 | 2 | 224 | 2 | 27602517 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 25998209 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 22677788 | ||
| Pubmed | Direct control of the Forkhead transcription factor AFX by protein kinase B. | 4.13e-05 | 2 | 224 | 2 | 10217147 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 23986482 | ||
| Pubmed | Ankyrin-B is required for intracellular sorting of structurally diverse Ca2+ homeostasis proteins. | 4.13e-05 | 2 | 224 | 2 | 10579720 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 24045955 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 22493503 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 21700933 | ||
| Pubmed | ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells. | 4.13e-05 | 2 | 224 | 2 | 23392125 | |
| Pubmed | ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. | 4.13e-05 | 2 | 224 | 2 | 17998143 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 24981175 | ||
| Pubmed | Integrin β3/Akt signaling contributes to platelet-induced hemangioendothelioma growth. | 4.13e-05 | 2 | 224 | 2 | 28744026 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 24983969 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 12422219 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 34958866 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 38804708 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 25412659 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 21505857 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 16272144 | ||
| Pubmed | [Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers]. | 4.13e-05 | 2 | 224 | 2 | 22169642 | |
| Pubmed | Integrin β3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK-Rearranged NSCLC. | 4.13e-05 | 2 | 224 | 2 | 29776956 | |
| Pubmed | The EGF/hnRNP Q1 axis is involved in tumorigenesis via the regulation of cell cycle-related genes. | 4.13e-05 | 2 | 224 | 2 | 29884818 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 25351247 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 27571988 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 34403156 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 17898861 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 23568740 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 26595804 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 36216811 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 18036246 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 18771760 | ||
| Pubmed | Receptor-binding domain of SARS-CoV-2 is a functional αv-integrin agonist. | 4.13e-05 | 2 | 224 | 2 | 36669646 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 24962568 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 19497978 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 11689711 | ||
| Pubmed | Expression of integrin cell adhesion receptors during human airway epithelial repair in vivo. | 4.13e-05 | 2 | 224 | 2 | 9252563 | |
| Pubmed | Role of coronin 1B in PDGF-induced migration of vascular smooth muscle cells. | 4.13e-05 | 2 | 224 | 2 | 22619279 | |
| Interaction | TAF9 interactions | TRRAP YIPF5 TAF1 PJA1 TAF7 TAF1L MAGEC2 IKZF3 ANK2 DRAP1 NCOR1 TAF3 | 2.04e-07 | 159 | 222 | 12 | int:TAF9 |
| Interaction | TAF9B interactions | 3.09e-06 | 108 | 222 | 9 | int:TAF9B | |
| Interaction | TOP3B interactions | TRPM4 RIN3 PCNX3 CYTH1 SPTB EXTL3 TRRAP MDN1 PLEKHM2 TLN2 AKT1 LTBP4 BCL2L13 ABTB2 SYNCRIP RAD51 HSPG2 FXR2 DYRK1A CHD8 SMG5 CORO1B PIP5K1C BAHD1 RABL6 NCOR1 THADA PWWP2B KANK3 NPRL3 ANKRD34A EHMT1 LRRC14 CABIN1 SPEN ATP2A3 | 4.95e-06 | 1470 | 222 | 36 | int:TOP3B |
| Interaction | TBP interactions | GTF3C4 RECQL4 TAF1 CPSF2 TAF7 TAF1L DYRK1A REST MED1 DRAP1 TAF3 ZNF76 MAPK7 | 4.95e-06 | 253 | 222 | 13 | int:TBP |
| Interaction | RFXANK interactions | 5.16e-06 | 146 | 222 | 10 | int:RFXANK | |
| Interaction | SIRT6 interactions | PATZ1 MCM3 TRRAP GTF3C4 RPS6KC1 AKT1 PLOD2 NXF1 SYNCRIP FAT4 FXR2 RGL3 DYRK1A CHD8 CORO1B MED1 ZBTB1 ZBTB10 EHMT1 MPHOSPH10 ZBTB11 | 6.64e-06 | 628 | 222 | 21 | int:SIRT6 |
| Interaction | SWSAP1 interactions | 3.33e-05 | 34 | 222 | 5 | int:SWSAP1 | |
| Interaction | P4HA3 interactions | 3.63e-05 | 113 | 222 | 8 | int:P4HA3 | |
| Cytoband | 9q34.13 | 1.43e-04 | 21 | 224 | 3 | 9q34.13 | |
| GeneFamily | Ankyrin repeat domain containing | BCORL1 TRPV2 ABTB2 NOTCH3 ANK2 PPP1R13B ANKRA2 KANK3 ANKRD34A EHMT1 TP53BP2 | 8.85e-06 | 242 | 157 | 11 | 403 |
| GeneFamily | CD molecules|Integrin beta subunits | 5.19e-05 | 9 | 157 | 3 | 1159 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.70e-04 | 134 | 157 | 7 | 861 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 4.44e-04 | 4 | 157 | 2 | 1244 | |
| GeneFamily | PWWP domain containing | 8.76e-04 | 22 | 157 | 3 | 1147 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.15e-03 | 53 | 157 | 4 | 532 | |
| GeneFamily | Biogenesis of lysosomal organelles complex 1 |BLOC-1 related complex | 2.03e-03 | 8 | 157 | 2 | 1048 | |
| GeneFamily | ATPases Ca2+ transporting | 2.59e-03 | 9 | 157 | 2 | 1209 | |
| Coexpression | GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP | BORCS6 RALGAPA1 CHRNA1 PJA1 BAIAP3 ABTB2 RAD17 IKZF3 DCLK1 VPS13B | 7.19e-06 | 196 | 222 | 10 | M8161 |
| Coexpression | GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP | PATZ1 MAP3K1 RHOBTB1 FHIP2B PPP1R13B ARID3B TAF3 TIGD2 NPRL3 | 7.35e-06 | 155 | 222 | 9 | M6844 |
| Coexpression | GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_DN | RALGAPA1 HDAC9 PDE8A ITGB8 MAP3K1 RPS6KC1 ABTB2 TBC1D30 REST TP53BP2 | 7.86e-06 | 198 | 222 | 10 | M8723 |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | ATP7B CYTH1 CYP27A1 GATA6 CHRNA1 TULP2 FOXO4 DMP1 VCAN ATP2A3 | 8.59e-06 | 200 | 222 | 10 | M8383 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | BNC2 RNF112 PDZD7 SCN9A RETREG1 TLN2 PLCB4 SULT4A1 UNC79 CNR1 CACNA1C ANK2 HCN3 PTPRT ZFHX4 FAM169A UNC13A DCLK1 SCAI | 9.61e-06 | 703 | 222 | 19 | M39070 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | BNC2 RNF112 PDZD7 SCN9A RETREG1 PLCB4 SULT4A1 UNC79 CNR1 CACNA1C FAT4 ANK2 HCN3 ZFHX4 FAM169A UNC13A DCLK1 | 1.12e-05 | 584 | 222 | 17 | M39068 |
| Coexpression | OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN | BNC2 GATA6 ITGB6 RHOBTB1 PLEKHM2 TRPV2 LTBP4 VCAM1 HSPG2 FER1L4 ATP2A3 | 2.40e-05 | 274 | 222 | 11 | M289 |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP | 2.43e-05 | 180 | 222 | 9 | M8127 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CYTH1 RNF112 PDZD7 MDN1 MTUS1 SCN9A RETREG1 TLN2 PLCB4 SULT4A1 UNC79 CNR1 CACNA1C IKZF3 ANK2 HCN3 AFF3 PTPRT ZFHX4 VCAN FAM169A UNC13A DCLK1 SCAI | 2.50e-05 | 1106 | 222 | 24 | M39071 |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN | 4.93e-05 | 197 | 222 | 9 | M5210 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_DN | 5.33e-05 | 199 | 222 | 9 | M6015 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN | CYTH1 EXTL3 UBE2G2 NXF1 ARHGEF18 ZBTB1 ARHGAP45 ATP2A3 VPS13B | 5.54e-05 | 200 | 222 | 9 | M8306 |
| Coexpression | GSE31622_WT_VS_KLF3_KO_BCELL_UP | 5.54e-05 | 200 | 222 | 9 | M8473 | |
| Coexpression | GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP | 5.54e-05 | 200 | 222 | 9 | M6713 | |
| Coexpression | LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE | 5.87e-05 | 49 | 222 | 5 | M2899 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL | CYP27A1 ITGB8 RHOBTB1 ALPK3 PLOD2 LTBP4 ANK2 ANPEP GLIS3 CXXC5 RAB11FIP1 PIP5K1C PWWP2B MAPK7 CABIN1 RAI2 | 6.26e-05 | 604 | 222 | 16 | M45760 |
| Coexpression | SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP | 7.54e-05 | 27 | 222 | 4 | M14614 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS | HDAC9 ALPK3 BAIAP3 ANK2 AFF3 GLIS3 TMEM63C TMEM132D UNC13A RAI2 ADAMTSL2 | 7.76e-05 | 312 | 222 | 11 | M39161 |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | MCM3 ADGRV1 CENPK ITGB8 PARPBP PLOD2 VCAM1 NOTCH3 DNMT3B RAD51 PITRM1 REST ZFHX4 | 8.82e-05 | 432 | 222 | 13 | MM419 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | HDAC9 CPSF2 TAF7 HS3ST3B1 ABTB2 CNR1 VCAM1 SYNCRIP FAT4 GLIS3 ZFHX4 MICALL2 VCAN DCLK1 SCAI | 1.10e-05 | 377 | 222 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | RALGAPA1 HDAC9 BNC2 SETX MYLK NASP EXTL3 TSPYL1 TLN2 PJA1 CPSF2 DMP1 CPLANE1 CNR1 FAT4 KRT15 TBC1D30 DYRK1A RBM20 ZFHX4 VCAN ASTN1 VPS13B | 1.35e-05 | 806 | 222 | 23 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | HDAC9 BNC2 SETX MYLK GATA6 ITGB3 YIPF5 ZNF469 TRPV2 CPSF2 TAF7 CPLANE1 PARPBP VCAM1 FAT4 AKAP5 KRT15 TBC1D30 SEC22B ZBTB1 NCOR1 ZFHX4 VCAN | 1.99e-05 | 826 | 222 | 23 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.50e-05 | 184 | 222 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | BNC2 SETX MYLK GATA6 ITGB3 YIPF5 ZNF469 CPSF2 VCAM1 FAT4 AKAP5 ZBTB1 NCOR1 ZFHX4 VCAN | 4.09e-05 | 422 | 222 | 15 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | RALGAPA1 SETX MYLK NASP EXTL3 AKT1 PLCB4 CPLANE1 ALK CNR1 FAT4 NPY2R KRT15 ANK2 TBC1D30 DYRK1A MED1 ZFHX4 VCAN ASTN1 DCLK1 VPS13B | 5.10e-05 | 818 | 222 | 22 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | HDAC9 BNC2 PATZ1 GATA6 NASP ITGB8 TULP2 INTS2 EID1 TAF7 CPLANE1 LTBP4 ABTB2 DDX4 CNR1 ZNF541 FHIP2B CHD8 REST KANK3 SCAI | 7.22e-05 | 778 | 222 | 21 | gudmap_developingGonad_e18.5_ovary_1000 |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | MCM3 CENPK ITGB3 RECQL4 HS3ST3B1 PARPBP RAD51 HCN3 ARHGEF18 MICALL2 | 1.81e-08 | 172 | 224 | 10 | e9b97f37bb1732ad9aa89c5e9b513d14022801ac |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.27e-08 | 183 | 224 | 10 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 4.01e-08 | 187 | 224 | 10 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYLK MTUS1 HS3ST3B1 PARPBP BAIAP3 NOTCH3 HCN3 ANKRD34A ASTN1 | 2.57e-07 | 174 | 224 | 9 | a0a059bb2a64d7011e206db2ebcdf3eb655a925a |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYLK MTUS1 HS3ST3B1 PARPBP BAIAP3 NOTCH3 HCN3 ANKRD34A ASTN1 | 2.57e-07 | 174 | 224 | 9 | 7cd6f9103133f8d7b90f9ff4b3b0b078cf554542 |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.97e-07 | 177 | 224 | 9 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | EML6 RETREG1 SULT4A1 UNC79 ANK2 TMEM63C AGBL4 TMEM132D UNC13A | 4.50e-07 | 186 | 224 | 9 | b45cce768e4bf91da194fd9660cab7520dfb15ac |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Acta2Rgs5.Fos_(Mural.Acta2Rgs5.Fos)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.80e-07 | 137 | 224 | 8 | 5ca712230a888403769547c2e03760131abaa4cf | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Acta2Rgs5.Fos_(Mural.Acta2Rgs5.Fos)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.80e-07 | 137 | 224 | 8 | 2282caba7a59d7c0d7a3de8b04a94a24fa01d10c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | SULT4A1 UNC79 BAIAP3 ERICH3 ANK2 TMEM63C AGBL4 TMEM132D UNC13A | 4.93e-07 | 188 | 224 | 9 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.38e-07 | 190 | 224 | 9 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.38e-07 | 190 | 224 | 9 | 0db545a4cba7534bad2693e0d565cde7dbc7a586 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 7.29e-07 | 197 | 224 | 9 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 7.29e-07 | 197 | 224 | 9 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.93e-07 | 199 | 224 | 9 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.26e-07 | 200 | 224 | 9 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | mild-B_intermediate|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.26e-07 | 200 | 224 | 9 | 8e3132a1fe3708f725c5c4077878fb87bbea3678 | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 1.16e-06 | 154 | 224 | 8 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.95e-06 | 165 | 224 | 8 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-06 | 166 | 224 | 8 | f4698fd08965936d51695d571bd10fb77330d916 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.14e-06 | 167 | 224 | 8 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.24e-06 | 168 | 224 | 8 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 2.34e-06 | 169 | 224 | 8 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 2.44e-06 | 170 | 224 | 8 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.03e-06 | 175 | 224 | 8 | 87e557f7508c88b2087db5d57e77d5e2c92ca083 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.30e-06 | 177 | 224 | 8 | 37d1abe1a9d8f2b8f4d146bbf1db94104eab6593 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-06 | 180 | 224 | 8 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.05e-06 | 182 | 224 | 8 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-06 | 184 | 224 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|lung / Disease (COVID-19 only), tissue and cell type | 4.39e-06 | 184 | 224 | 8 | 480595a0e2e6aa2a77b7daa36490ae3af3d8dfee | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-06 | 184 | 224 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-06 | 184 | 224 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.57e-06 | 185 | 224 | 8 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-06 | 186 | 224 | 8 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 4.75e-06 | 186 | 224 | 8 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.95e-06 | 187 | 224 | 8 | 69b47f00598d647e2a99427ebddf42c339428e47 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.14e-06 | 188 | 224 | 8 | 6f53bcd4caab2fc961af799039ea5c3ddae56781 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.14e-06 | 188 | 224 | 8 | 9256c5f45c97df209bb9c322c3b557d4f726a333 | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.35e-06 | 189 | 224 | 8 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-06 | 189 | 224 | 8 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-06 | 190 | 224 | 8 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-06 | 191 | 224 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.78e-06 | 191 | 224 | 8 | 03f6da73e7b706252d2096507222229c4101a27b | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.78e-06 | 191 | 224 | 8 | 578b58782e816ecaeabfbc616ceb1dcd53ee428b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 191 | 224 | 8 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | Ciliated-cil-3|World / Class top | 6.00e-06 | 192 | 224 | 8 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.00e-06 | 192 | 224 | 8 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.24e-06 | 193 | 224 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.48e-06 | 194 | 224 | 8 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.48e-06 | 194 | 224 | 8 | 5d30d3d41d5f19cdf3077cc609aa2738762cb8c5 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.48e-06 | 194 | 224 | 8 | 582db7f7fa9aa08027ae18ed607945b5d1dc908a | |
| ToppCell | COVID-19_Severe-B_intermediate|COVID-19_Severe / disease group, cell group and cell class | 6.48e-06 | 194 | 224 | 8 | 3418308da7f1278ae2bf3fb61fc361b222e30043 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.48e-06 | 194 | 224 | 8 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.48e-06 | 194 | 224 | 8 | bda89111386398a072b70e8153b2a762298a047a | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 195 | 224 | 8 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.52e-06 | 198 | 224 | 8 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.52e-06 | 198 | 224 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.80e-06 | 199 | 224 | 8 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Lymphocytic-B_cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.09e-06 | 200 | 224 | 8 | 2fb3cf5c7a03c3874390a111bba15203599d4859 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Lymphocytic-B_cells-B-cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.09e-06 | 200 | 224 | 8 | 4c8007a158f0f6b6fa259b25d2387b648bb2fc0d | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.51e-06 | 144 | 224 | 7 | e9d62f202f0fa8747961036ef0eafed91fe8a42f | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.90e-06 | 145 | 224 | 7 | ac41c6c02b7d78162b86222983688f54d04ac47d | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-05 | 100 | 224 | 6 | cb0deaf1c33d2789417e93cc01d94e34a611d20a | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.62e-05 | 159 | 224 | 7 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.62e-05 | 159 | 224 | 7 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 159 | 224 | 7 | c960df9e4fa980401941866b5081facac4590b4d | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 159 | 224 | 7 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | Control-MAIT|World / Disease group and Cell class | 1.90e-05 | 163 | 224 | 7 | 0ca4b835936b4f82217cbe57210c1dd90986c1d0 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.06e-05 | 165 | 224 | 7 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.06e-05 | 165 | 224 | 7 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.06e-05 | 165 | 224 | 7 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | Ionocyte|World / shred by cell class for turbinate | 2.06e-05 | 165 | 224 | 7 | 0cb2199b87f17ece743fb2652b2f448dfa78ae0b | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.06e-05 | 165 | 224 | 7 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.14e-05 | 166 | 224 | 7 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Lung / Manually curated celltypes from each tissue | 2.23e-05 | 167 | 224 | 7 | dcbcc658082910838c8082d71a64917055086cc4 | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 2.31e-05 | 168 | 224 | 7 | 4bf3f85aac4b335efa93d22c9ce7b153cb5ce152 | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 2.31e-05 | 168 | 224 | 7 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 168 | 224 | 7 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 169 | 224 | 7 | 2d23b4cee060f8adddc430c1c10d4e25205b4af6 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-05 | 169 | 224 | 7 | b66ffc2b2b6bfcc3a6e639d9d31d3de95f4a94e1 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 169 | 224 | 7 | ecaf08e8e0b54d1c97a02bc1f65409fd43d68227 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 169 | 224 | 7 | ad6af6609acf158cb79e45ee7ca9af332be3c40c | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 2.50e-05 | 170 | 224 | 7 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-05 | 170 | 224 | 7 | 92e0873f618b2fa60c4d555b10f234d5cbcf3325 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-05 | 170 | 224 | 7 | c181991f933b779f99afc3782f292306f209e2ac | |
| ToppCell | LPS-IL1RA-Lymphocytic_B|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-05 | 170 | 224 | 7 | 56284fbfd1e53f67c8c0b7fba64505a4002adba2 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.59e-05 | 171 | 224 | 7 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 2.69e-05 | 172 | 224 | 7 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.69e-05 | 172 | 224 | 7 | 03a0aff6b7971093a4347b5ed12546d78374c56f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.79e-05 | 173 | 224 | 7 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.79e-05 | 173 | 224 | 7 | 5c55e1e27e9e3e77600d378cc87b51cc73907527 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.90e-05 | 174 | 224 | 7 | c988471207ba06195bc3e41056435e8c31c20bbe | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-05 | 174 | 224 | 7 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.90e-05 | 174 | 224 | 7 | 9f2e253694eb5860c00528fda31c305c6de8a2a1 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-05 | 174 | 224 | 7 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-05 | 174 | 224 | 7 | 3503c7dec498597f76a86dbd5e4bb2311e743bde | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-05 | 174 | 224 | 7 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.12e-05 | 176 | 224 | 7 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 3.12e-05 | 176 | 224 | 7 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.12e-05 | 176 | 224 | 7 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| Drug | Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | TRPM4 CYTH1 GATA6 RHOBTB1 FXR2 REST NCOR1 MICALL2 LRRC14 ARHGAP45 PRKX | 2.94e-06 | 191 | 222 | 11 | 7220_DN |
| Drug | Tridihexethyl chloride; Up 200; 11.4uM; MCF7; HT_HG-U133A | RIN3 MYLK EXTL3 ITGB8 DMP1 LTBP4 NOTCH3 FXR2 PIP5K1C ATP2A1 ATP2A3 | 3.42e-06 | 194 | 222 | 11 | 3526_UP |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | ZNF609 MYLK SYNC SSH3 LTBP4 ZBTB1 ZNF710 ZFHX4 MAPK7 ATP2A3 PRKX | 3.77e-06 | 196 | 222 | 11 | 3256_UP |
| Drug | Dichlorphenamide [120-97-8]; Down 200; 13.2uM; HL60; HT_HG-U133A | BORCS6 SSH3 TRPV2 TLN2 FOXO4 THAP3 HSPG2 TFAP4 ZNF710 ZNF76 MAPK7 | 3.96e-06 | 197 | 222 | 11 | 3027_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | ZNF609 ZMPSTE24 ANPEP SMG5 MED1 ZNF710 THADA ANKRA2 VCAN MRTO4 MPHOSPH10 | 3.96e-06 | 197 | 222 | 11 | 1732_DN |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; MCF7; HT_HG-U133A | GON4L SYNC EXTL3 LTBP4 FHIP2B KRT15 TBC1D30 TFAP4 RABL6 MAPK7 CABIN1 | 3.96e-06 | 197 | 222 | 11 | 2228_DN |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A | CYTH1 SSH3 TLN2 CPLANE1 NOTCH3 HSPG2 ZBTB1 VCAN ZBTB10 MAPK7 CABIN1 | 4.16e-06 | 198 | 222 | 11 | 6668_DN |
| Drug | AC1L1GTQ | 1.40e-05 | 54 | 222 | 6 | CID000003836 | |
| Drug | PTK/ZK | 1.74e-05 | 56 | 222 | 6 | CID000151193 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | XIRP1 MYLK GGN PLCB4 CACNA1C AKAP5 ANK2 EHMT1 CABIN1 ATP2A1 ATP2A3 | 1.93e-05 | 233 | 222 | 11 | CID000005114 |
| Drug | Delcorine; Down 200; 8.4uM; PC3; HT_HG-U133A | PDGFB CYTH1 SEPTIN6 SSH3 RETREG1 BAIAP3 SMG5 TFAP4 NPRL3 PRKX | 2.19e-05 | 194 | 222 | 10 | 4275_DN |
| Drug | Hypertensin II | PDGFB GGN ITGB3 MAP3K1 MTUS1 AKT1 PLCB4 PLS3 VCAM1 CACNA1C ANPEP EGF CABIN1 ATP2A1 ATP2A3 | 2.24e-05 | 429 | 222 | 15 | CID000025476 |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; PC3; HT_HG-U133A | ZNF609 ALPK3 BAIAP3 ALK RAD51 HSPG2 AKAP5 RABL6 ZNF76 VPS13B | 2.29e-05 | 195 | 222 | 10 | 6626_UP |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; PC3; HT_HG-U133A | TRPM4 ZNF609 PDGFB SYNC MTUS1 CPLANE1 HSPG2 FAT4 CABIN1 ARHGAP45 | 2.39e-05 | 196 | 222 | 10 | 4548_DN |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.39e-05 | 196 | 222 | 10 | 7027_DN | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | PDGFB PATZ1 CYTH1 SCN9A RETREG1 NOTCH3 BAHD1 TFAP4 VCAN MAPK7 | 2.39e-05 | 196 | 222 | 10 | 5757_DN |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | ITGB3 SEPTIN6 CPLANE1 LTBP4 BAIAP3 NPY2R C11orf16 RFX2 VCAN VPS13B | 2.50e-05 | 197 | 222 | 10 | 2267_UP |
| Drug | Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; HL60; HT_HG-U133A | ZNF609 ATP7B CYTH1 SPTB ITGB8 MAP3K1 TLN2 FOXO4 SULT4A1 AFF3 | 2.50e-05 | 197 | 222 | 10 | 2954_UP |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; HL60; HT_HG-U133A | RIN3 BCORL1 GON4L RETREG1 PLOD2 BCL2L13 MOCOS RAD51 MICALL2 ZNF76 | 2.50e-05 | 197 | 222 | 10 | 2975_DN |
| Drug | Benperidol [2062-84-2]; Up 200; 10.4uM; HL60; HT_HG-U133A | RALGAPA1 BNC2 MYLK PDGFB CYP27A1 SSH3 SULT4A1 PPP1R13B EHMT1 ATP2A3 | 2.50e-05 | 197 | 222 | 10 | 2475_UP |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; PC3; HT_HG-U133A | GATA6 NASP EXTL3 RHOBTB1 SSH3 NOTCH3 HSPG2 SMG5 ZBTB1 SCARB2 | 2.50e-05 | 197 | 222 | 10 | 5865_DN |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; MCF7; HT_HG-U133A | BORCS6 TRPM4 ZNF609 PDGFB TLN2 SULT4A1 BAHD1 MICALL2 ZNF76 LRRC14 | 2.50e-05 | 197 | 222 | 10 | 1540_DN |
| Drug | Glycopyrrolate [596-51-0]; Down 200; 10uM; HL60; HT_HG-U133A | BORCS6 PDE8A MAP3K1 RETREG1 DMP1 DNMT3B RAD51 ZNF710 VCAN MAPK7 | 2.50e-05 | 197 | 222 | 10 | 2565_DN |
| Drug | Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | BORCS6 ZNF609 MYLK BCORL1 RAD51 SMG5 REST TFAP4 MAPK7 ARHGAP45 | 2.61e-05 | 198 | 222 | 10 | 6083_DN |
| Drug | Dienestrol [84-17-3]; Down 200; 15uM; PC3; HT_HG-U133A | PDGFB NASP SSH3 SCN9A SULT4A1 ZNF710 RABL6 MAPK7 CABIN1 RAI2 | 2.61e-05 | 198 | 222 | 10 | 5727_DN |
| Drug | Clorgyline hydrochloride [17780-75-5]; Up 200; 13uM; MCF7; HT_HG-U133A | 2.61e-05 | 198 | 222 | 10 | 3219_UP | |
| Drug | PF-00539758-00 [351321-34-1]; Down 200; 10uM; PC3; HT_HG-U133A | RALGAPA1 RIN3 PDGFB SPTB CPLANE1 SULT4A1 LTBP4 VCAN ZNF76 MAPK7 | 2.61e-05 | 198 | 222 | 10 | 6421_DN |
| Drug | Trolox [53188-07-1]; Up 200; 16uM; MCF7; HT_HG-U133A | RIN3 PDGFB CYTH1 LTBP4 BAIAP3 C11orf16 ZNF76 MAPK7 ATP2A3 VPS13B | 2.72e-05 | 199 | 222 | 10 | 6007_UP |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; HL60; HT_HG-U133A | PDGFB PDZD7 SSH3 TRPV2 FOXO4 SULT4A1 REST MICALL2 SCARB2 PRKX | 2.84e-05 | 200 | 222 | 10 | 2348_UP |
| Drug | Azacyclonol [115-46-8]; Down 200; 15uM; PC3; HT_HG-U133A | PDGFB EXTL3 MTUS1 ARHGEF6 NOTCH3 MED1 PIP5K1C BAHD1 EGF MAPK7 | 2.84e-05 | 200 | 222 | 10 | 6298_DN |
| Drug | Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.84e-05 | 200 | 222 | 10 | 6246_UP | |
| Drug | Leu-asp-val | 3.77e-05 | 20 | 222 | 4 | CID000130816 | |
| Drug | vanadyl | PDE8A PDGFB MAP3K1 MTUS1 AKT1 MAGEC2 VCAM1 EGF MAPK7 CABIN1 ATP2A1 ATP2A3 | 5.20e-05 | 307 | 222 | 12 | CID000061671 |
| Drug | mercuric bromide | MYLK PDGFB GATA6 ITGB6 RETREG1 HS3ST3B1 PLOD2 VCAM1 C11orf52 NPY2R GLIS3 RFX2 RBM20 THADA PWWP2B EGF TMEM132D TKT FAM169A KNDC1 ZBTB10 NPRL3 ASTN1 PRKX RAI2 | 5.41e-05 | 1076 | 222 | 25 | ctd:C042720 |
| Drug | (2s,5s)-5-Carboxymethylproline | PDGFB ITGB3 ITGB6 PLOD2 PLS3 DDX4 VCAM1 HSPG2 NPY2R ANPEP MED1 NCOR1 | 6.45e-05 | 314 | 222 | 12 | CID000447989 |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A | 6.57e-05 | 178 | 222 | 9 | 6193_DN | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; PC3; HT_HG-U133A | 9.59e-05 | 187 | 222 | 9 | 4589_UP | |
| Drug | AC1L9M2J | 9.94e-05 | 76 | 222 | 6 | CID000448538 | |
| Drug | orthovanadate | ATP7B PDE8A PDGFB SSTR1 ALPK3 AKT1 KIF17 MAGEC2 PLS3 EGF SCARB2 MAPK7 ATP2A1 ATP2A3 | 1.02e-04 | 435 | 222 | 14 | CID000061672 |
| Drug | thioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 1.04e-04 | 189 | 222 | 9 | 1171_DN | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; HL60; HT_HG-U133A | 1.08e-04 | 190 | 222 | 9 | 3041_DN | |
| Drug | 5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 1.08e-04 | 190 | 222 | 9 | 970_UP | |
| Drug | AC1L1G0K | 1.13e-04 | 49 | 222 | 5 | CID000003473 | |
| Drug | tetrathiomolybdate | 1.15e-04 | 78 | 222 | 6 | ctd:C020809 | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.22e-04 | 193 | 222 | 9 | 3262_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 1.22e-04 | 193 | 222 | 9 | 1048_DN | |
| Drug | Decamethonium bromide [541-22-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.22e-04 | 193 | 222 | 9 | 4174_UP | |
| Drug | Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.22e-04 | 193 | 222 | 9 | 5271_UP | |
| Drug | CGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A | 1.27e-04 | 194 | 222 | 9 | 6417_DN | |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; PC3; HT_HG-U133A | 1.27e-04 | 194 | 222 | 9 | 6729_DN | |
| Drug | Enalapril maleate [76095-16-4]; Down 200; 8.2uM; HL60; HT_HG-U133A | 1.27e-04 | 194 | 222 | 9 | 2397_DN | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 222 | 9 | 4734_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; PC3; HT_HG-U133A | 1.32e-04 | 195 | 222 | 9 | 5763_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.32e-04 | 195 | 222 | 9 | 6654_DN | |
| Drug | Isosorbide dinitrate [87-33-2]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 222 | 9 | 4742_DN | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 222 | 9 | 5608_UP | |
| Drug | Loracarbef [121961-22-6]; Up 200; 10.8uM; HL60; HT_HG-U133A | 1.32e-04 | 195 | 222 | 9 | 2970_UP | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 1.32e-04 | 195 | 222 | 9 | 6614_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.37e-04 | 196 | 222 | 9 | 5863_UP | |
| Drug | sulfasalazine; Down 200; 100uM; MCF7; HG-U133A | 1.37e-04 | 196 | 222 | 9 | 204_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.37e-04 | 196 | 222 | 9 | 2232_DN | |
| Drug | Levonordefrin [829-74-3]; Down 200; 21.8uM; HL60; HT_HG-U133A | 1.37e-04 | 196 | 222 | 9 | 2710_DN | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; HL60; HT_HG-U133A | 1.37e-04 | 196 | 222 | 9 | 3055_UP | |
| Drug | Anabasine [494-52-0]; Up 200; 24.6uM; MCF7; HT_HG-U133A | 1.37e-04 | 196 | 222 | 9 | 6774_UP | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; HL60; HT_HG-U133A | 1.37e-04 | 196 | 222 | 9 | 2406_DN | |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; HL60; HT_HG-U133A | 1.37e-04 | 196 | 222 | 9 | 3049_DN | |
| Drug | 1-phenylbiguanide hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 1.42e-04 | 197 | 222 | 9 | 22_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 4207_DN | |
| Drug | Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; HL60; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 2972_DN | |
| Drug | LY 294002; Up 200; 0.1uM; PC3; HT_HG-U133A | RALGAPA1 CYTH1 GON4L CHRNA1 ALPK3 TBC1D30 ZNF76 CABIN1 UNC13A | 1.42e-04 | 197 | 222 | 9 | 1216_UP |
| Drug | Aminohippuric acid [61-78-9]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 5394_UP | |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 5766_DN | |
| Drug | Glimepiride [93479-97-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 2809_UP | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 6611_DN | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A_EA | ZNF609 PDGFB CYP17A1 BCORL1 TBC1D30 DYRK1A MED1 ASTN1 CABIN1 | 1.42e-04 | 197 | 222 | 9 | 984_UP |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 3616_UP | |
| Drug | Lansoprazole [103577-45-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A | PDGFB EXTL3 PLEKHM2 RETREG1 LTBP4 BAIAP3 ARHGEF6 ZNF76 ATP2A3 | 1.42e-04 | 197 | 222 | 9 | 6009_UP |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 5735_DN | |
| Drug | 20,25-diazacholesterol | 1.42e-04 | 11 | 222 | 3 | CID000009402 | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.48e-04 | 198 | 222 | 9 | 3175_DN | |
| Drug | SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A | ZNF609 PLEKHM2 RETREG1 LTBP4 BAIAP3 MED1 CABIN1 ATP2A3 UNC13A | 1.48e-04 | 198 | 222 | 9 | 4977_UP |
| Drug | thioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 1.48e-04 | 198 | 222 | 9 | 6189_DN | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | BORCS6 RALGAPA1 EXTL3 PLEKHM2 RETREG1 KRT15 TBC1D30 MED1 MAPK7 | 1.48e-04 | 198 | 222 | 9 | 6812_DN |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.48e-04 | 198 | 222 | 9 | 5621_DN | |
| Drug | Chlorogenic acid [327-97-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.48e-04 | 198 | 222 | 9 | 4142_UP | |
| Drug | Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.48e-04 | 198 | 222 | 9 | 2123_DN | |
| Drug | Bethanechol chloride [590-63-6]; Up 200; 20.4uM; PC3; HT_HG-U133A | 1.48e-04 | 198 | 222 | 9 | 5114_UP | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; PC3; HT_HG-U133A | 1.48e-04 | 198 | 222 | 9 | 6656_UP | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | RALGAPA1 PDGFB CYP27A1 TAF1 BAIAP3 ARHGEF6 ZNF710 RABL6 MICALL2 | 1.48e-04 | 198 | 222 | 9 | 7557_DN |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; HL60; HT_HG-U133A | RALGAPA1 ZNF609 BCORL1 MAP3K1 KIF17 DNMT3B BAHD1 ZNF710 MAPK7 | 1.48e-04 | 198 | 222 | 9 | 2724_DN |
| Drug | Amidopyrine [58-15-1]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.48e-04 | 198 | 222 | 9 | 6818_DN | |
| Drug | BAPTA-AM | MYLK PDGFB AKT1 PLCB4 PLS3 CACNA1C EGF TMEM132D CABIN1 ATP2A1 ATP2A3 | 1.52e-04 | 293 | 222 | 11 | CID000002293 |
| Drug | Ciprofibrate [52214-84-3]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.54e-04 | 199 | 222 | 9 | 5740_DN | |
| Drug | Piretanide [55837-27-9]; Down 200; 11uM; PC3; HT_HG-U133A | 1.54e-04 | 199 | 222 | 9 | 4490_DN | |
| Drug | Lymecycline [992-21-2]; Up 200; 6.6uM; HL60; HT_HG-U133A | 1.54e-04 | 199 | 222 | 9 | 2953_UP | |
| Drug | Gabapentin [60142-96-3]; Down 200; 23.4uM; PC3; HT_HG-U133A | 1.54e-04 | 199 | 222 | 9 | 5875_DN | |
| Drug | Niflumic acid [4394-00-7]; Down 200; 14.2uM; HL60; HT_HG-U133A | 1.54e-04 | 199 | 222 | 9 | 2399_DN | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Up 200; 3uM; MCF7; HT_HG-U133A | 1.54e-04 | 199 | 222 | 9 | 2244_UP | |
| Drug | Lymecycline [992-21-2]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.54e-04 | 199 | 222 | 9 | 5994_UP | |
| Drug | rapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.54e-04 | 199 | 222 | 9 | 5975_DN | |
| Disease | Malignant neoplasm of breast | XIRP1 ATP7B CYP17A1 BCORL1 MAP3K1 AKT1 ALK MAGEC2 PLS3 NOTCH3 ZNF541 DNMT3B RAD51 ANK2 PPHLN1 RFX2 HELQ EPG5 NCOR1 EGF ANKRD34A EHMT1 SPEN ATP2A3 VPS13B TP53BP2 | 1.45e-07 | 1074 | 220 | 26 | C0006142 |
| Disease | pancreatitis (is_marker_for) | 4.04e-06 | 5 | 220 | 3 | DOID:4989 (is_marker_for) | |
| Disease | mean platelet volume | HDAC9 RIN3 CFAP251 PCNX3 BCORL1 EML6 MCM3 ITGB3 SEPTIN6 TMEM171 TAF7 PLS3 ZNF584 PCDHGA1 AFF3 DYRK1A REST RFX2 TFAP4 ZNF710 ZBTB10 ARHGAP45 | 8.88e-06 | 1020 | 220 | 22 | EFO_0004584 |
| Disease | Usher syndrome, type 2C | 5.53e-05 | 2 | 220 | 2 | C2931213 | |
| Disease | USHER SYNDROME, TYPE IIC | 5.53e-05 | 2 | 220 | 2 | 605472 | |
| Disease | Usher syndrome type 2C | 5.53e-05 | 2 | 220 | 2 | cv:C2931213 | |
| Disease | Usher syndrome type 2C (is_implicated_in) | 5.53e-05 | 2 | 220 | 2 | DOID:0110839 (is_implicated_in) | |
| Disease | FEV/FEC ratio | HDAC9 BNC2 PDGFB GATA6 NASP ITGB8 MAP3K1 BORCS5 MTUS1 PJA1 TAF7 LTBP4 HSPG2 PCDHGA1 AFF3 GLIS3 ARHGEF18 REST TFAP4 AGBL4 THADA ATP2A3 | 1.40e-04 | 1228 | 220 | 22 | EFO_0004713 |
| Disease | Brody myopathy (implicated_via_orthology) | 1.65e-04 | 3 | 220 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | hair colour measurement | HDAC9 BNC2 RIN3 PDGFB ADGRV1 ITGB3 MAP3K1 ZNF469 UBE2G2 CPSF2 TBC1D30 EPG5 THADA ZNF76 | 2.33e-04 | 615 | 220 | 14 | EFO_0007822 |
| Disease | Cutaneous Melanoma | 2.45e-04 | 41 | 220 | 4 | C0151779 | |
| Disease | erythritol measurement | 2.57e-04 | 17 | 220 | 3 | EFO_0021171 | |
| Disease | Antibody Deficiency Syndrome | 2.57e-04 | 17 | 220 | 3 | C0003257 | |
| Disease | Neuropathy, Hereditary Sensory And Autonomic, Type IIA | 3.29e-04 | 4 | 220 | 2 | C2752089 | |
| Disease | Hereditary sensory and autonomic neuropathy type 2 | 3.29e-04 | 4 | 220 | 2 | cv:C5574675 | |
| Disease | Neuropathy, hereditary sensory and autonomic, type 2A | 3.29e-04 | 4 | 220 | 2 | cv:C2752089 | |
| Disease | NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA | 3.29e-04 | 4 | 220 | 2 | 201300 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 2 | 5.45e-04 | 5 | 220 | 2 | C0020072 | |
| Disease | paraplegia (biomarker_via_orthology) | 5.45e-04 | 5 | 220 | 2 | DOID:607 (biomarker_via_orthology) | |
| Disease | Intellectual Disability | RALGAPA1 GON4L TRRAP TAF1 PJA1 PITRM1 AFF3 CHD8 RABL6 ASTN1 ZBTB11 | 5.73e-04 | 447 | 220 | 11 | C3714756 |
| Disease | Mammary Carcinoma, Human | ATP7B CYP17A1 MAP3K1 AKT1 ALK NOTCH3 DNMT3B RAD51 NCOR1 EGF ANKRD34A TP53BP2 | 6.24e-04 | 525 | 220 | 12 | C4704874 |
| Disease | Mammary Neoplasms, Human | ATP7B CYP17A1 MAP3K1 AKT1 ALK NOTCH3 DNMT3B RAD51 NCOR1 EGF ANKRD34A TP53BP2 | 6.24e-04 | 525 | 220 | 12 | C1257931 |
| Disease | Mammary Neoplasms | ATP7B CYP17A1 MAP3K1 AKT1 ALK NOTCH3 DNMT3B RAD51 NCOR1 EGF ANKRD34A TP53BP2 | 6.45e-04 | 527 | 220 | 12 | C1458155 |
| Disease | Immunologic Deficiency Syndromes | 6.49e-04 | 23 | 220 | 3 | C0021051 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.80e-04 | 195 | 220 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | Brugada Syndrome (disorder) | 7.37e-04 | 24 | 220 | 3 | C1142166 | |
| Disease | triacylglycerol 56:4 measurement | 7.37e-04 | 24 | 220 | 3 | EFO_0010431 | |
| Disease | Breast Carcinoma | ATP7B CYP17A1 MAP3K1 AKT1 ALK NOTCH3 DNMT3B RAD51 NCOR1 EGF ANKRD34A TP53BP2 | 7.72e-04 | 538 | 220 | 12 | C0678222 |
| Disease | Sensory Neuropathy, Hereditary | 8.14e-04 | 6 | 220 | 2 | C0699739 | |
| Disease | Antihypertensive use measurement | 8.89e-04 | 265 | 220 | 8 | EFO_0009927 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.13e-03 | 7 | 220 | 2 | C0020075 | |
| Disease | Calcium channel blocker use measurement | 1.14e-03 | 213 | 220 | 7 | EFO_0009930 | |
| Disease | Fibrosis, Liver | 1.16e-03 | 105 | 220 | 5 | C0239946 | |
| Disease | cortical surface area measurement | HDAC9 BNC2 RIN3 PDE8A PCNX3 SYNC EXTL3 ADGRV1 ITGB8 MAP3K1 ZNF469 TLN2 HS3ST3B1 GLIS3 REST TFAP4 NCOR1 THADA TIGD2 VCAN DCLK1 | 1.18e-03 | 1345 | 220 | 21 | EFO_0010736 |
| Disease | Cerebrovascular accident | 1.20e-03 | 62 | 220 | 4 | C0038454 | |
| Disease | glutamate measurement | 1.29e-03 | 29 | 220 | 3 | EFO_0010487 | |
| Disease | susceptibility to hepatitis B infection measurement | 1.35e-03 | 64 | 220 | 4 | EFO_0008405 | |
| Disease | Endometrioma | 1.35e-03 | 161 | 220 | 6 | C0269102 | |
| Disease | Endometriosis | 1.35e-03 | 161 | 220 | 6 | C0014175 | |
| Disease | Epilepsy | 1.37e-03 | 109 | 220 | 5 | C0014544 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 1.43e-03 | 30 | 220 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | lymphocyte count | HDAC9 PDGFB SPTB EML6 TMEM171 ZNF469 BORCS5 VCAM1 RAD17 DNMT3B IKZF3 PCDHGA1 GLIS3 ARHGEF18 REST ZBTB1 PTPRT ZNF710 NCOR1 THADA EGF ARHGAP45 | 1.47e-03 | 1464 | 220 | 22 | EFO_0004587 |
| Disease | Glioblastoma Multiforme | 1.49e-03 | 111 | 220 | 5 | C1621958 | |
| Disease | disease recurrence, malaria | 1.50e-03 | 8 | 220 | 2 | EFO_0001068, EFO_0004952 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 1.58e-03 | 31 | 220 | 3 | C1335167 | |
| Disease | Large cell carcinoma of lung | 1.73e-03 | 32 | 220 | 3 | C0345958 | |
| Disease | eosinophil count | BNC2 RIN3 PDE8A PATZ1 ITGB3 ITGB6 ITGB8 GTF3C4 FNDC1 MDN1 LTBP4 BCL2L13 VCAM1 IKZF3 COX5B DYRK1A ARHGEF18 REST THADA TIGD2 ARHGAP45 ATP2A3 | 1.80e-03 | 1488 | 220 | 22 | EFO_0004842 |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.92e-03 | 9 | 220 | 2 | C3502809 | |
| Disease | colorectal adenocarcinoma (is_implicated_in) | 2.24e-03 | 35 | 220 | 3 | DOID:0050861 (is_implicated_in) | |
| Disease | Anemia, Sickle Cell | 2.39e-03 | 10 | 220 | 2 | C0002895 | |
| Disease | Cannabis Abuse | 2.39e-03 | 10 | 220 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 2.39e-03 | 10 | 220 | 2 | C0236735 | |
| Disease | Facies | 2.39e-03 | 10 | 220 | 2 | C0282631 | |
| Disease | triacylglycerol 54:1 measurement | 2.39e-03 | 10 | 220 | 2 | EFO_0010419 | |
| Disease | Hashish Abuse | 2.39e-03 | 10 | 220 | 2 | C0018614 | |
| Disease | neutrophil-to-lymphocyte ratio | 2.73e-03 | 185 | 220 | 6 | EFO_0008447 | |
| Disease | facial morphology measurement | HDAC9 BNC2 CFAP251 DNMT3B FAT4 GLIS3 PTPRT THADA TMEM132D VPS13B | 2.76e-03 | 466 | 220 | 10 | EFO_0007841 |
| Disease | nicotine dependence | 2.79e-03 | 78 | 220 | 4 | EFO_0003768 | |
| Disease | nitric oxide exhalation measurement | 2.85e-03 | 38 | 220 | 3 | EFO_0005536 | |
| Disease | neuroimaging measurement | HDAC9 PDE8A MAP3K1 RETREG3 ZNF469 BORCS5 TLN2 AFF3 GLIS3 CXXC5 TFAP4 NCOR1 THADA ZBTB32 VCAN DCLK1 SCAI | 2.86e-03 | 1069 | 220 | 17 | EFO_0004346 |
| Disease | Glioblastoma | 2.92e-03 | 79 | 220 | 4 | C0017636 | |
| Disease | thyroid stimulating hormone measurement | 3.06e-03 | 323 | 220 | 8 | EFO_0004748 | |
| Disease | Hypercholesterolemia | 3.07e-03 | 39 | 220 | 3 | C0020443 | |
| Disease | body surface area | RALGAPA1 BNC2 BRPF3 CYTH1 ITGB3 ITGB8 UNC79 CXXC5 TFAP4 AGBL4 MICALL2 NPRL3 | 3.40e-03 | 643 | 220 | 12 | EFO_0022196 |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.48e-03 | 12 | 220 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Gastrointestinal Diseases | 3.48e-03 | 12 | 220 | 2 | C0017178 | |
| Disease | Functional Gastrointestinal Disorders | 3.48e-03 | 12 | 220 | 2 | C0559031 | |
| Disease | Cholera Infantum | 3.48e-03 | 12 | 220 | 2 | C1565321 | |
| Disease | anxiety disorder, stress-related disorder | 3.48e-03 | 12 | 220 | 2 | EFO_0006788, EFO_0010098 | |
| Disease | Giant Cell Glioblastoma | 3.64e-03 | 84 | 220 | 4 | C0334588 | |
| Disease | alanine measurement | 3.96e-03 | 86 | 220 | 4 | EFO_0009765 | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 4.09e-03 | 13 | 220 | 2 | C0270914 | |
| Disease | tyrosine-protein kinase receptor Tie-1, soluble measurement | 4.09e-03 | 13 | 220 | 2 | EFO_0008312 | |
| Disease | gallbladder cancer (is_implicated_in) | 4.09e-03 | 13 | 220 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | cancer (implicated_via_orthology) | 4.13e-03 | 268 | 220 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | PR interval | HDAC9 PCNX3 PSMA5 ZNF469 MTUS1 ALPK3 CNR1 HSPG2 PPHLN1 TFAP4 | 4.22e-03 | 495 | 220 | 10 | EFO_0004462 |
| Disease | lymphocyte percentage of leukocytes | HDAC9 RIN3 BORCS5 BCL2L13 VCAM1 DNMT3B IKZF3 GLIS3 ARHGEF18 ZNF710 THADA ARHGAP45 | 4.43e-03 | 665 | 220 | 12 | EFO_0007993 |
| Disease | ureteral obstruction (biomarker_via_orthology) | 4.61e-03 | 45 | 220 | 3 | DOID:5199 (biomarker_via_orthology) | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 4.61e-03 | 45 | 220 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Impaired cognition | 4.75e-03 | 14 | 220 | 2 | C0338656 | |
| Disease | ovarian serous carcinoma | 4.90e-03 | 46 | 220 | 3 | EFO_1001516 | |
| Disease | Salivary Gland Neoplasms | 5.21e-03 | 47 | 220 | 3 | C0036095 | |
| Disease | reticulocyte count | BNC2 PATZ1 SPTB CYP27A1 EML6 MAP3K1 ZNF469 TLN2 BAIAP3 REST THADA EGF KANK3 NPRL3 PALM3 ARHGAP45 | 5.41e-03 | 1045 | 220 | 16 | EFO_0007986 |
| Disease | platelet crit | HDAC9 RIN3 PDGFB ADGRV1 PJA1 NOTCH3 CACNA1C AFF3 CXXC5 REST EPG5 THADA EGF ZNF76 TANGO2 | 5.42e-03 | 952 | 220 | 15 | EFO_0007985 |
| Disease | autoimmune thrombocytopenic purpura (is_implicated_in) | 5.45e-03 | 15 | 220 | 2 | DOID:8924 (is_implicated_in) | |
| Disease | response to olanzapine | 5.45e-03 | 15 | 220 | 2 | GO_0097333 | |
| Disease | impotence (implicated_via_orthology) | 5.45e-03 | 15 | 220 | 2 | DOID:1875 (implicated_via_orthology) | |
| Disease | Rhabdomyosarcoma | 5.45e-03 | 15 | 220 | 2 | C0035412 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 5.75e-03 | 152 | 220 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | neuroimaging measurement, brain volume measurement | 5.85e-03 | 286 | 220 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | Seizures | 6.04e-03 | 218 | 220 | 6 | C0036572 | |
| Disease | platelet-to-lymphocyte ratio | 6.13e-03 | 363 | 220 | 8 | EFO_0008446 | |
| Disease | suicide | 6.19e-03 | 50 | 220 | 3 | EFO_0007624 | |
| Disease | Fibrosis | 6.19e-03 | 50 | 220 | 3 | C0016059 | |
| Disease | Cirrhosis | 6.19e-03 | 50 | 220 | 3 | C1623038 | |
| Disease | Neuralgia, Supraorbital | 6.20e-03 | 16 | 220 | 2 | C0038870 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 6.20e-03 | 16 | 220 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Neuralgia | 6.20e-03 | 16 | 220 | 2 | C0027796 | |
| Disease | Spondyloepiphyseal Dysplasia | 6.20e-03 | 16 | 220 | 2 | C0038015 | |
| Disease | Neuralgia, Atypical | 6.20e-03 | 16 | 220 | 2 | C0234247 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PREDEEGQEGQDSMS | 431 | Q9UPW8 | |
| QAGREAGTDMQESQP | 241 | Q15361 | |
| AGTDMQESQPTVGLD | 246 | Q15361 | |
| SEVGADMQESRPAVG | 301 | Q15361 | |
| DSGAGDEAPMSDLQA | 366 | Q8N6Y0 | |
| MDPEEVKSLDSNGAG | 281 | Q9BXK5 | |
| EEMDFRSGSPSDNSG | 116 | P31749 | |
| RSGSPSDNSGAEEME | 121 | P31749 | |
| PDNGTSNTSMLEDDL | 356 | P51826 | |
| NMNSEPEEEDGGLED | 86 | Q8IVW6 | |
| EMGSDAENEAPVEAS | 1121 | Q5RHP9 | |
| DASGQNESEMFDVPL | 71 | Q9HCE0 | |
| TQLGPITGEMDEADS | 366 | Q6ZSZ5 | |
| SSLDSLDQMNQDGGG | 41 | Q9HCK8 | |
| LSLTMSQDGFPNEDG | 2121 | Q9HCK8 | |
| ELEQFMENQGASSPG | 351 | Q15052 | |
| VFMEQGSGEAAADPE | 1831 | P13611 | |
| NNDLDPDECMQRTGG | 166 | Q9NQI0 | |
| ESGLTNGDEPMDQDL | 501 | Q9P2I0 | |
| QQGGMESPQVEADSG | 196 | Q9UBC3 | |
| AGTMGPDQVDDEEAL | 151 | O94812 | |
| EDDDPNDGGAVVNDM | 656 | Q6ZN30 | |
| GDGVNDSPALAQADM | 1266 | P35670 | |
| EDINDNGPMLTVSEG | 3501 | Q6V0I7 | |
| MILGGPQSDSDTDAQ | 201 | Q8NB90 | |
| GGDIRMNQGPEESES | 941 | Q5H9F3 | |
| DNDDLAGMDISFPET | 5126 | Q8WXG9 | |
| GSAPTAMEGQSEQEV | 916 | Q96L96 | |
| EEPMALQELDSSNGA | 256 | Q9BR76 | |
| GERSPQQEEETGMTN | 986 | Q9ULD4 | |
| SDQIGLPDFNAGAME | 341 | P15144 | |
| LDPNSEEGSAQGVAM | 36 | Q9H9E1 | |
| TGEPLFSGANEVDQM | 356 | Q13627 | |
| SDISSDGEREANMPG | 86 | Q6UXS9 | |
| SPSQDFMGTLADVDN | 746 | Q96KQ4 | |
| EDVGNASTENSDMPA | 811 | Q13625 | |
| EITAMTGDGVNDAPA | 696 | O14983 | |
| EITAMTGDGVNDAPA | 696 | Q93084 | |
| EGSDCGESRELPMNQ | 716 | O14525 | |
| VNEGDAQGETALMAA | 31 | Q69YU3 | |
| MSDAAEAPREATGEN | 1 | Q8TBY9 | |
| LVASVPDMQGDGEDN | 86 | Q14919 | |
| NSQGEESMGNAEPLR | 481 | Q9Y5P3 | |
| AGKEEQEGMEESPQS | 851 | Q5T481 | |
| GSEGNADGAQIQEML | 151 | P98160 | |
| HGMIDPDSGDEAQLN | 606 | O75943 | |
| PEAEAMFAINADGVG | 321 | Q06609 | |
| GDGLKMENDPQEAES | 111 | Q3YEC7 | |
| MENDLSEGVNPSVGR | 461 | Q9NWS1 | |
| MGPIGAEADENQTVE | 1 | P49146 | |
| EGSESQAEEMNEAGP | 546 | A6NDB9 | |
| VMNGPRELDGAQDSD | 51 | Q68G75 | |
| ESDQPDLSNFMESGE | 181 | P02708 | |
| GDDSLPSSQFLDGMN | 871 | Q01484 | |
| LNQSFDMGVADGPQD | 751 | Q13164 | |
| LMPVGDNNFSDSEEG | 76 | Q13127 | |
| QSDSGSEGEMEEPTV | 211 | Q5JU00 | |
| SGLSPFMGDNDNETL | 1656 | Q15746 | |
| PGQADNERSMGDHNE | 5101 | Q9NU22 | |
| ANTLEDGGMTPQLAE | 111 | A8MTJ3 | |
| GASAFEQADLNGMTP | 666 | Q92619 | |
| GKEMAEGAASPEEQS | 101 | Q9Y662 | |
| DEGSDDEGMPENSLL | 216 | Q9UBF1 | |
| SDGPNMTENGLEDES | 566 | P51116 | |
| SDGMEVPNDSALQEF | 296 | Q9ULD2 | |
| AELDDGMASNQNSPI | 176 | Q96S38 | |
| EMDDPGDSDGVNLIS | 1131 | A9Z1Z3 | |
| GLLENGDSVTSPENM | 1336 | Q9BY66 | |
| VCSSMDENDGPGEEV | 361 | O15075 | |
| GTMNNQPEEGEEESG | 766 | Q9P1W3 | |
| VNGNGTEEPMDTTSA | 6 | O60506 | |
| DMSTSLQEGQEDGPA | 571 | Q8IY33 | |
| RSGAQQLEEEGPMEE | 46 | Q9Y6B2 | |
| DPGEEDGAELDLNMT | 51 | P01127 | |
| STMGELEEEPAQGDS | 96 | Q9H6A9 | |
| EGEPRIDINMSGFNE | 316 | P13797 | |
| NSHMPAETEELDGGT | 226 | Q86V87 | |
| MDPGNENSATEAAAI | 1 | P98177 | |
| IDTPEGGFDAIMQAA | 236 | P18564 | |
| DGDVAMSDAQDGPRV | 56 | Q9UBU9 | |
| ADTAMQTEPDAGGRV | 366 | Q9H5P4 | |
| DDDPHANDLVGGLMS | 436 | O60658 | |
| MASGGGVPTDEEQAT | 31 | P10606 | |
| EVSAMADGNEGPQSP | 176 | Q12980 | |
| NGSRDTGSMDPDVQL | 1171 | Q9H0H0 | |
| PQGDADADGMDVNVR | 1771 | Q9UM47 | |
| AMNRGINDGGDLPEE | 216 | Q15438 | |
| GMPIGESENLFDDSL | 756 | P09848 | |
| MGNDDPEMGERAENS | 141 | O00566 | |
| LDMELGPSQGQETNE | 391 | Q86TH1 | |
| GDNMDLIDGQPTGSV | 451 | Q96EN8 | |
| AGQVNVEMDAAPGVD | 256 | P19012 | |
| LQFGEEDADPGAMSR | 121 | P28066 | |
| EGEMAQPADSESGLS | 226 | Q86UU5 | |
| DGSELDDEGMQSDDP | 206 | Q13316 | |
| MEAEQRPAAGASEGA | 1 | Q9P1Z3 | |
| SEACAEEEEGLMPQG | 226 | Q3MIN7 | |
| PDMEAVAGAEALNGQ | 191 | Q7LFL8 | |
| GDAVPSGNEVSENME | 746 | P49321 | |
| GPEENLSQAEARNMG | 361 | O00469 | |
| QSGAQREMGPVASAD | 791 | O14522 | |
| GIAGSMQPEEEAARA | 201 | Q9HBE1 | |
| GEQDGDAMPLGSAVD | 511 | P25205 | |
| DTPEGGFDAMLQAAV | 251 | P26012 | |
| MTGAGESTNPENSEL | 546 | Q92908 | |
| PGGGMDVEQQEEEDN | 131 | Q96GS4 | |
| RPVAMDAGDSADQSG | 1731 | Q9Y6J0 | |
| EMESAADNILSGGAP | 2156 | Q13936 | |
| DVPFEMLQDDNTSAG | 2526 | Q9H799 | |
| GEDGQAADGSMQPTS | 1116 | P01133 | |
| DDSMLGPSQNFEAES | 136 | Q9Y3I1 | |
| DDDGNLIMSSNGIPE | 1521 | Q4ZHG4 | |
| AGTDPNMADNGDLDL | 561 | O43909 | |
| NMADNGDLDLGPVET | 566 | O43909 | |
| MNSDNGNAGPDQDSE | 271 | P05093 | |
| ALPQATLDDDGEMDG | 326 | Q8NEA6 | |
| MNQEDLDPDSTTDVG | 1 | Q9BS16 | |
| EDMEAQLQAAGPDGI | 291 | Q02318 | |
| GGLFIPMEEQDNEES | 226 | Q3T8J9 | |
| MGSEQSSEAESRPND | 1 | Q969J3 | |
| QSAPEAGNDMGNDDA | 6 | Q5VU57 | |
| LEGEMQPAINAEDAD | 101 | P24588 | |
| EDSNMEQGVEGVEPG | 26 | Q8TBE0 | |
| EGTAQPLDNSMGDSD | 416 | P21554 | |
| ATMSNEERSDGGFPN | 531 | Q9Y6X4 | |
| MGFQPNTAGSECEDV | 781 | Q8N2S1 | |
| NRDAPEGGFDAIMQA | 241 | P05106 | |
| QESSPGSMDGDRAVA | 426 | Q6NY19 | |
| QMDGVGGTSENDDPS | 336 | O75449 | |
| GNVCFMEQLSDDPEG | 91 | Q76NI1 | |
| EGVSNGMLETAPQEG | 596 | Q6ZMW3 | |
| VGDQPNDSEVDMFGD | 96 | Q8TDG4 | |
| GDQAMQEDRAPSSGN | 511 | Q9UKV0 | |
| QPDVASSRDGMDNET | 121 | P54792 | |
| EDSGMEPRNEEEGNS | 296 | O75844 | |
| EMENVDSGEGPANED | 36 | Q9UKT9 | |
| MEPGVQDLGLSSSED | 1 | A0A1B0GTI1 | |
| EEGDAEVMQLGSSSP | 71 | Q6NUJ5 | |
| ADGLPLAASMQEDEQ | 11 | O75396 | |
| PMAADEGSAEKQAGE | 31 | Q9H9B1 | |
| LATPENFDVDGGMDQ | 21 | Q16820 | |
| NTEMDHDGTPENEGE | 356 | Q8NEY8 | |
| GEDPLDGQMGVSTNS | 1321 | Q15648 | |
| QQMGDDLPESASEST | 216 | Q9UKD2 | |
| SLEDQSPGMAAEGDQ | 396 | Q8TB24 | |
| LLMVNATDPDEGANG | 261 | Q9Y5H4 | |
| VGGQQAEAPDSVAMS | 81 | Q6ZRI0 | |
| EDSGVDEGQGSPSEM | 566 | Q8IWE5 | |
| TSAADNGEPNMEDDR | 921 | Q9P2E2 | |
| DGSEMNHLAAESPGE | 221 | Q13233 | |
| EQVPTDGGTSAEAMQ | 141 | Q5VWG9 | |
| DGGTSAEAMQVPLEE | 146 | Q5VWG9 | |
| EAENQGLDISSPGMS | 191 | Q15545 | |
| LEQADAPTSQAGGME | 461 | Q9H7C4 | |
| GDLRENMAPANSEAT | 406 | Q6WKZ4 | |
| DGMEEPGRNASQNGT | 36 | P30872 | |
| DPEIEMSGGLVNGSS | 406 | P19320 | |
| ETVANTVDSDMGEPN | 1301 | Q6YHU6 | |
| MEAGESASPANILED | 481 | Q15147 | |
| TLAQGAGEEDPSGMV | 956 | Q9UPR3 | |
| QVDLPRSNGEMDGND | 891 | Q14C87 | |
| DDMGDEQRGSEAGPD | 686 | P48378 | |
| DLSDFPSLENGMGTN | 346 | Q9H6L5 | |
| PSLENGMGTNDEDEL | 351 | Q9H6L5 | |
| EDPGQGSSSVEFDMV | 976 | O94761 | |
| EMGPQEATQAESEDG | 211 | Q8IZX4 | |
| EMGPQEATQAESEDG | 191 | P21675 | |
| DMVGSPDQDLQEAAA | 1011 | Q5T2S8 | |
| IESDDTMGGIPAVNG | 371 | O60331 | |
| GGDSDMAAAQPGTEI | 2221 | O75376 | |
| TPAGDLQETFSGMDQ | 731 | Q5JRX3 | |
| IAPGESDLENMNAEE | 1091 | Q15858 | |
| DNNGEMPLFDITGQD | 91 | Q7Z333 | |
| QGSMDEGTADERAPL | 461 | Q14108 | |
| FLMECEESPNGSEGA | 296 | O94844 | |
| MEDANAVRGSASQGP | 521 | Q96PQ1 | |
| PTDDESVAEINGTMN | 216 | Q14141 | |
| EPGGSSEQEQMEQAI | 261 | Q8TE77 | |
| AIEALGPDGVNTMDD | 506 | Q8N961 | |
| EEASQMDLLDGPGAE | 296 | Q9UM73 | |
| NAASNNDPEMDGEDG | 941 | Q9UM73 | |
| NDPEMDGEDGVSFIS | 946 | Q9UM73 | |
| MGLDEDNEPDNEGCN | 296 | O00327 | |
| SCEQDGVENDLEMGP | 341 | Q9NQ32 | |
| GSQERSPGLMSEDSN | 61 | Q96A22 | |
| INMDPAGLDDEDDTS | 336 | Q86VR2 | |
| GNEENSGMNIDEGAI | 391 | Q4W5G0 | |
| EPSNMDGNSGDADCF | 331 | P32780 | |
| AGMEPDRENSSTDDN | 36 | Q86UP3 | |
| PEDSGMGNDISAEDI | 451 | O95625 | |
| GMQEQESSGPQELET | 971 | O95625 | |
| PGTRAEGESDSQDMG | 171 | O00295 | |
| ETNMSGGGEQADILP | 11 | Q5TCY1 | |
| SDIGGSSANVPDLMD | 826 | Q6GYQ0 | |
| AGAQALQPSEEGMET | 2251 | Q96T58 | |
| RMNQGHASPGDTDDD | 366 | Q9ULX5 | |
| IGEDGPSQMALEDLA | 421 | P29401 | |
| TPQFLGMEDGDNERT | 126 | Q7Z6I5 | |
| GADPDEIGLMNIDEQ | 71 | Q9BR01 | |
| APAEDGMSAELQGEA | 56 | A8MU46 | |
| GMSAELQGEANGLDE | 61 | A8MU46 | |
| MAAAAEGPQQSAEGS | 311 | Q5TF21 | |
| EATQVMAEPGEGGSE | 41 | Q9H0U9 | |
| TDENTGQEPSMEGRS | 271 | Q9ULZ2 | |
| NDGSDDGPSVMDETS | 606 | O15014 | |
| ATESVQPMEGQEDEG | 571 | Q9Y5S1 | |
| GTDPSELDGQQEMED | 616 | Q8N1W2 | |
| IMSSGGAEDDIPQGE | 41 | Q8N9R8 | |
| TFNERSNPDDDSMGI | 281 | Q9Y2I9 | |
| EAAPASQLEGEMSGQ | 481 | Q9BWV7 | |
| QVPSMGEEGGDADLS | 1441 | P11277 | |
| MSPAAAAEPDGDQQD | 1 | Q8WVE6 | |
| MNTADQARVGPADDG | 1 | Q9UKN8 | |
| ILLVDSPGMGNADDE | 606 | Q9UKN8 | |
| SPGMGNADDEQQEEG | 611 | Q9UKN8 | |
| MQDTINEFGGTPEEN | 646 | Q8NDW8 | |
| MEAPGLAQAAAAESD | 1 | P51817 | |
| VADGSIMNETDLAGP | 116 | Q969M3 | |
| DGGSMAQEADDAPSI | 376 | Q9H8X9 | |
| GPGVMEGAAETDQEA | 2671 | Q96JG9 | |
| GEPQDLTMNGLGNTE | 471 | Q9Y2K1 | |
| DGEEDFVGNDPASTM | 361 | Q7Z7G8 | |
| GQMAAATAEPEEIGF | 1901 | Q9Y4G6 | |
| ADCPAALENQDMGTG | 141 | Q8N567 | |
| AQLSPGEMEESDQGH | 326 | Q9Y2Y4 | |
| DGSPEMAENESEGQT | 541 | Q96DT7 | |
| AGAGEDSPGRNMDTA | 116 | Q8WTV1 | |
| PGVFMLDGNNNLEDD | 486 | Q8NG27 | |
| SDAMDQSREEPSGDG | 321 | Q01664 | |
| PDSDMDPNSSGEGVN | 2026 | Q9Y4A5 | |
| GSSGNIEDMDPELQQ | 866 | Q702N8 | |
| MAGEAEAQLDPSLQG | 1 | Q8IVC4 | |
| MDSVINGEGPVGTAD | 726 | Q8TD43 | |
| FEDGQPVQLEDGSMA | 56 | P36508 | |
| GNNNEILSGLDMEEG | 41 | Q6ICL3 | |
| MLAEPNDESGANVDA | 126 | P60604 | |
| MDQYSLGDEGALPSE | 1 | Q9H0D2 | |
| DEEEETMNQGDDGPS | 1646 | Q9P2D8 | |
| GLLDDGVEQDPGTMS | 121 | Q15048 | |
| QAQPGATEESCMVGD | 76 | Q9BTE0 |